World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
56
Citations
13362
World Ranking
3679
National Ranking
1445

Veronica Miller publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Veronica Miller sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 149 publications — 26th percentile

26% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Veronica Miller D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Veronica Miller sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 56 D-Index — 34th percentile

34% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Veronica Miller is affiliated with the University of California, Berkeley in the United States. Their research primarily focuses on medicine, with significant contributions in epidemiology, infectious diseases, hepatology, virology, and endocrinology, diabetes, and metabolism.

Their main topics of research include liver disease diagnosis and treatment, hepatitis C virus research, HIV/AIDS research and interventions, hepatitis B virus studies, HIV research and treatment, diet, metabolism, and disease, and HIV/AIDS drug development and treatment.

Veronica Miller has published extensively, with recent papers highlighting various aspects of liver diseases, viral infections, and therapies. Notable recent publications include:

  • "Advancing the global public health agenda for NAFLD: a consensus statement" (2021) in Nature Reviews Gastroenterology & Hepatology
  • "A roadmap for serum biomarkers for hepatitis B virus: current status and future outlook" (2022) in Nature Reviews Gastroenterology & Hepatology
  • "NAFLD - sounding the alarm on a silent epidemic" (2020) in Nature Reviews Gastroenterology & Hepatology
  • "Antiretroviral therapy alone versus antiretroviral therapy with a kick and kill approach, on measures of the HIV reservoir in participants with recent HIV infection (the RIVER trial): a phase 2, randomised trial" (2020) in The Lancet
  • "Association Between Seroclearance of Hepatitis B Surface Antigen and Long-term Clinical Outcomes of Patients With Chronic Hepatitis B Virus Infection: Systematic Review and Meta-analysis" (2020) in Clinical Gastroenterology and Hepatology

Frequently, Miller collaborates with other researchers. Their prominent coauthors include Gabriel Westman, Arun J. Sanyal, Sven Francque, Jörn M. Schattenberg, and Sarah Fidler.

Miller's work appears regularly in journals such as the Journal of Hepatology, Nature Reviews Gastroenterology & Hepatology, Clinical Infectious Diseases, Journal of Virus Eradication, and Hepatology.

The research topics and publication venues reflect a strong focus on liver diseases and viral infections, particularly those affecting public health at large. The combination of epidemiological approaches and clinical studies marks Miller's contributions to advancing understanding and treatment options in infectious and metabolic diseases.

Best Publications

  • Changing patterns of mortality across Europe in patients infected with HIV-1.

    A Mocroft;S Vella;TL Benfield;A Chiesi

  • Definitions of Cytomegalovirus Infection and Disease in Transplant Patients for Use in Clinical Trials.

    Per Ljungman;Per Ljungman;Michael Boeckh;Michael Boeckh;Hans H Hirsch;Filip Josephson

  • Advancing the global public health agenda for NAFLD: a consensus statement.

    Jeffrey V Lazarus;Henry E Mark;Quentin M Anstee;Juan Pablo Arab

  • A Rapid Method for Simultaneous Detection of Phenotypic Resistance to Inhibitors of Protease and Reverse Transcriptase in Recombinant Human Immunodeficiency Virus Type 1 Isolates from Patients Treated with Antiretroviral Drugs

    Kurt Hertogs;Marie-Pierre de Béthune;Veronica Miller;Tania Ivens

  • A global scientific strategy to cure hepatitis B

    Peter A Revill;Francis V Chisari;Joan M Block;Maura Dandri

  • The relation between baseline HIV drug resistance and response to antiretroviral therapy: re-analysis of retrospective and prospective studies using a standardized data analysis plan

    Victor DeGruttola;Lynn Dix;Richard D'Aquila;Dan Holder

  • HIV-1 protease and reverse transcriptase mutations for drug resistance surveillance.

    Robert W. Shafer;Soo-Yon Rhee;Deenan Pillay;Veronica Miller

  • HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viral load.

    Andrew N. Phillips;Schlomo Staszewski;Rainer Weber;Ole Kirk

  • Non-Hodgkin lymphoma in HIV-infected patients in the era of highly active antiretroviral therapy

    Ole Kirk;Court Pedersen;Alessandro Cozzi-Lepri;Francisco Antunes

  • Hepatitis C virus drug resistance–associated substitutions: State of the art summary

    Erik Lontok;Patrick Harrington;Anita Howe;Tara Kieffer

  • Virological and immunological effects of treatment interruptions in HIV-1 infected patients with treatment failure

    Veronica Miller;Caroline Sabin;Kurt Hertogs;Stuart Bloor

  • Phenotypic and genotypic analysis of clinical HIV-1 isolates reveals extensive protease inhibitor cross-resistance: a survey of over 6000 samples.

    K. Hertogs;S. Bloor;S. D. Kemp;C. van den Eynde

  • Relations among CD4 lymphocyte count nadir, antiretroviral therapy, and HIV-1 disease progression: results from the EuroSIDA study.

    V Miller;A Mocroft;P Reiss;C Katlama

  • Definitions of Resistant and Refractory Cytomegalovirus Infection and Disease in Transplant Recipients for Use in Clinical Trials.

    Roy F. Chemaly;Sunwen Chou;Hermann Einsele;Paul Griffiths

  • Protein binding in antiretroviral therapies.

    Marta Boffito;David J. Back;Terrence F. Blaschke;Malcolm Rowland

  • A family of insertion mutations between codons 67 and 70 of human immunodeficiency virus type 1 reverse transcriptase confer multinucleoside analog resistance.

    B. A. Larder;S. Bloor;S. D. Kemp;Kurt Hertogs

  • HIV-1 Viral Load Assays for Resource-Limited Settings

    Susan A Fiscus;Ben Cheng;Suzanne M Crowe;Lisa Demeter

  • Recommendations for analytical antiretroviral treatment interruptions in HIV research trials—report of a consensus meeting

    Boris Julg;Boris Julg;Lynda Dee;Jintanat Ananworanich;Dan H Barouch;Dan H Barouch

  • Updated European recommendations for the clinical use of HIV drug resistance testing

    A. M. Vandamme;A. Sönnerborg;M. Ait-Khaled;J. Albert

  • HIV-1 reverse transcriptase (RT) genotype and susceptibility to RT inhibitors during abacavir monotherapy and combination therapy.

    Veronica Miller;Mounir Ait-Khaled;Chris Stone;Philip Griffin

Frequent Co-Authors

Schlomo Staszewski
Schlomo Staszewski Goethe University Frankfurt
Andrew N. Phillips
Andrew N. Phillips University College London
Jens D. Lundgren
Jens D. Lundgren Rigshospitalet
Kurt Hertogs
Kurt Hertogs AZ Monica
Caroline Sabin
Caroline Sabin University College London
Daniel R. Kuritzkes
Daniel R. Kuritzkes Brigham and Women's Hospital
Arun J. Sanyal
Arun J. Sanyal Virginia Commonwealth University
Holger F. Rabenau
Holger F. Rabenau Goethe University Frankfurt

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors to diverse career paths, many of which can be further supported by related online degrees. For example, those interested in medical fields might consider exploring what medical degrees can I get online, offering flexible study options to complement microbiology knowledge.

Public health is another relevant field, with many students opting for an advanced degree to broaden their impact. Popular choices include affordable and accessible programs like the online public health masters programs easy to get into, which are designed to accommodate diverse schedules and backgrounds.

For those aiming to work closely with children and families, the role of a child life specialist combines healthcare and psychology. Understanding salary expectations and career requirements is crucial, and resources such as child specialist salary provide valuable insights.

Importantly, online degree options are increasingly inclusive, offering opportunities for students from various backgrounds. For those facing challenges such as past convictions, exploring college degrees for felons helps identify supportive programs that facilitate career advancement in scientific fields.

Best Scientists Citing Veronica Miller

Trending Scientists

Recently Published Articles